- Penrith Panthers win fourth straight NRL title after downing Storm
- Weary Sinner happy for day off after battling into Shanghai last 16
- Pakistan's Masood warns England still a force without Stokes
- Madrid's Carvajal to miss several months after serious knee injury
- Israel pounds Lebanon ahead of Hamas attack anniversary
- Two elephants die in flash flooding in northern Thailand
- Sabalenka targets world number one and Wuhan hat-trick
- Toddler among 4 dead in migrant Channel crossings
- Tunisia votes with Saied set for re-election
- Bagnaia sets 'example' with Japan MotoGP win to cut gap on Martin
- Intense Israeli bombing rocks Beirut ahead of war anniversary
- Mozambique vote: no suspense but some disillusion
- Austrian rapper channels anti-racist rage in Romani hip-hop songs
- Ohtani magic powers Dodgers over Padres in MLB playoff thriller
- Five of the best: Pakistan-England Test thrillers
- Man sets arm on fire as marches across US mark Gaza war anniversary
- Vietnam's young coffee entrepreneurs brew up a revolution
- Trump rallies at site of failed assassination: 'Never quit'
- Too hot by day, Dubai's floodlit beaches are packed at night
- Is music finally reckoning with #MeToo?
- Fans hail Trump's 'guts' as he returns to site of rally shooting
- Lebanon state media says 'very violent' Israeli strikes hit south Beirut
- Guardians maul Tigers, miracle Mets rally in MLB series openers
- Lebanon state media says Israeli strikes hit south Beirut
- Miami on track for MLS record points after win in Toronto
- Madrid beat Villarreal but Carvajal suffers knee injury
- Madrid beat Villarreal to move level with Liga leaders Barcelona
- Monaco take top spot in Ligue 1 with win at Rennes
- French rugby player on rape charge whistled but 'serene' on return
- Madrid beat Villarreal to level Liga leaders Barca
- Thuram treble fires Inter past Torino and up to second
- 'Fight': defiant Trump jets in to site of rally shooting
- Toddler among 3 dead in migrant Channel crossings
- Mexico City's new mayor sworn in with pledges on water, housing
- Israel on alert ahead of Hamas attack anniversary
- Guardians maul Tigers in MLB playoff series opener
- Macron criticises Israel on Gaza, Lebanon operations
- French rugby player whistled but 'serene' on return amid ongoing rape case
- Kovacic stars as Man City sink Fulham to get title bid back on track
- Retegui hat-trick fires five-star Atalanta to hammering of Genoa
- Heavyweights Australia, England off to World Cup winning starts
- Visiting UN refugee agency chief decries 'terrible crisis' in Lebanon
- Spinners come to party as England defeat Bangladesh at T20 World Cup
- Search continues for missing in deadly Bosnia floods
- Man City sink Fulham to get title bid back on track
- France's Auradou whistled on Pau return in Perpignan loss amid ongoing rape case
- A 'forgotten' valley in storm-hit North Carolina, desperate for help
- Arsenal hit back in style after Southampton scare
- Thousands march for Palestinians ahead of Oct 7 anniversary
- Hezbollah heir apparent Safieddine out of contact after strikes
US authorizes fourth Covid shot for over 50s
The United States Tuesday authorized a fourth dose of either the Pfizer-BioNTech or Moderna Covid-19 vaccines for people 50 and older, as authorities warn of a possible new wave driven by the BA.2 variant.
The Food and Drug Administration (FDA) said in a statement it had based its decision on emerging evidence that an additional booster, given four months after the last, improved protection against severe Covid and wasn't associated with new safety concerns.
Additionally, people with immune compromising conditions who have already received four shots, with their latest at least four months ago, are now eligible for a fifth dose.
That includes people living with certain organ transplants.
The Pfizer vaccine will be available to immune compromised people aged 12 and over, while the Moderna vaccine will be available to those 18 and up.
"Current evidence suggests some waning of protection over time against serious outcomes from Covid-19 in older and immunocompromised individuals," senior FDA scientist Peter Marks said, explaining the decision.
The FDA said data from Israel, which had studied the effects of a fourth dose given four months after the third on 700,000 people, found the extra shot was safe.
It also cited data from a study of 154 health workers whose antibody levels, including against the Delta and Omicron variants, were restored to high levels two weeks after their fourth doses.
A study published by Israeli researchers in the New England Journal of Medicine this month indicated that three doses of current generation mRNA vaccines have hit a ceiling in terms of the immune response generated.
In other words, while three doses brings immunity levels to new heights, the fourth dose restores antibody levels to where they previously were shortly after the third.
Experts have said the benefits to younger, healthy people aren't yet clear, and say new vaccines will likely need to be developed as the virus continues to mutate.
F.Schneider--AMWN